Clinical Trials Logo

Tyrosinemia, Type III clinical trials

View clinical trials related to Tyrosinemia, Type III.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06298292 Not yet recruiting - Alkaptonuria Clinical Trials

Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

ZeroMinisMR
Start date: April 1, 2024
Phase:
Study type: Observational

The purpose of this prospective, observational study is to evaluate the tolerability and acceptability of Zero minis, a range of protein substitute tablets for use in the dietary management of children with either TYROSINAEMIA Type I, II, III or ALKAPTONURIA, HOMOCYSTINURIA, or MAPLE SYRUP URINE DISEASE (MSUD) over the age of 7 years.